Avoro Capital Advisors LLC - Mar 31, 2025 SCHEDULE 13G/A Report for Amicus Therapeutics, Inc. Common Stock, par value $0.01 per share (FOLD)

Filing Manager
Avoro Capital Advisors LLC
Reporting Manager
Avoro Capital Advisors LLC
Security
Amicus Therapeutics, Inc. Common Stock, par value $0.01 per share
Symbol
FOLD
Shares outstanding
306M shares
Disclosed Ownership
20.5M shares
Ownership
6.7%
Form type
SCHEDULE 13G/A
Date filed
5/15/2025, 09:30 AM
Date of event
Mar 31, 2025
Next filing
Nov 14, 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Avoro Capital Advisors LLC 6.7% 20.5M 20.5M 0 /s/ Scott Epstein Scott Epstein, Chief Financial Officer & Chief Compliance Officer
Behzad Aghazadeh 6.7% 20.5M 20.5M 0 /s/ Behzad Aghazadeh Behzad Aghazadeh, Individually